(RTTNews) - Bausch Health Companies Inc. (BHC, BHC.TO) and its gastroenterology unit Salix Pharmaceuticals, announced on Monday that a six-month pilot study of a standardized clinical pathway for Cirrhosis management improved adherence to guideline-based monitoring and treatment
Nous affichons publiquement l'idee principale. Creez un compte gratuit pour lire l'article complet, l'enregistrer, le commenter et le relier au contexte marches et OSINT.